Ethel M. Koczon
Chief Tech/Sci/R&D Officer at CHIASMA, INC.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Patrick O'Neil | M | 50 | 23 years | |
| Elizabeth Hougen | F | 62 | 24 years | |
| Spencer Berthelsen | M | 71 | 22 years | |
| Sanjay Bhanot | M | - | 24 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Roni Mamluk | M | 57 | 15 years | |
| Mark J. Fitzpatrick | M | 61 | 6 years | |
| David Kabakoff | M | 76 |
Salmedix, Inc.
 Salmedix, Inc. Pharmaceuticals: MajorHealth Technology Salmedix, Inc. develops oncology and small molecule drugs to treat hematological malignancies. The company's product, Treanda, is currently in Phase II clinical trials in the United States and Canada for the treatment of indolent (slowly progressing) non-Hodgkin's lymphoma. It was founded in 2000 and is located in San Diego, CA. | 4 years |
| Mark Leuchtenberger | M | 67 | 1 years | |
| Rajkumar Kannan | M | 61 | 2 years | |
| David Stack | M | 72 | 7 years | |
| Jason Fredette | M | - | 1 years | |
| Chaime Orlev | M | 53 | 6 years | |
| Dror Brandwein | M | - | 3 years | |
| Anand Varadan | M | 57 | 3 years | |
| Tara Mccarthy | F | 50 | - | |
| Dawn Schottlandt | F | - | 1 years | |
| Scott Minick | M | 72 | 14 years | |
| John Scarlett | M | 73 | 6 years | |
| Drew Enamait | M | 50 | 6 years | |
| Julie A. Crawford | F | - |
Salmedix, Inc.
Salmedix, Inc. Pharmaceuticals: MajorHealth Technology Salmedix, Inc. develops oncology and small molecule drugs to treat hematological malignancies. The company's product, Treanda, is currently in Phase II clinical trials in the United States and Canada for the treatment of indolent (slowly progressing) non-Hodgkin's lymphoma. It was founded in 2000 and is located in San Diego, CA. | 4 years |
| John Reed | M | 65 | 11 years | |
| Frederick Muto | M | 70 | 21 years | |
| F. Andrew Dorr | M | - |
Salmedix, Inc.
Salmedix, Inc. Pharmaceuticals: MajorHealth Technology Salmedix, Inc. develops oncology and small molecule drugs to treat hematological malignancies. The company's product, Treanda, is currently in Phase II clinical trials in the United States and Canada for the treatment of indolent (slowly progressing) non-Hodgkin's lymphoma. It was founded in 2000 and is located in San Diego, CA. | 8 years |
| Ansbert Gadicke | M | 66 | 2 years | |
| John Thero | M | 63 | 6 years | |
| lee Giguere | M | 43 | 2 years | |
| James Tobin | M | 79 | 1 years | |
| John Doyle | M | 46 | - | |
| Vincent J. Miles | M | 73 | 3 years | |
| Karen Potts | M | 61 | 3 years | |
| Pratik Multani | M | 57 |
Salmedix, Inc.
Salmedix, Inc. Pharmaceuticals: MajorHealth Technology Salmedix, Inc. develops oncology and small molecule drugs to treat hematological malignancies. The company's product, Treanda, is currently in Phase II clinical trials in the United States and Canada for the treatment of indolent (slowly progressing) non-Hodgkin's lymphoma. It was founded in 2000 and is located in San Diego, CA. | 1 years |
| David Plante | M | - | 3 years | |
| Asi Haviv | M | - | 9 years | |
| Neil Abdollahian | M | 51 | 1 years | |
| Daniel Ripley | M | 63 | 6 years | |
| Joseph Lyons | M | - | 1 years | |
| Shoshie Katz | F | - | 14 years | |
| Derek Brown | M | - | 2 years | |
| David H. Schubert | M | - | 2 years | |
| William Ludlam | M | 59 | 6 years | |
| Gary J. G. Atkinson | M | 71 | 5 years | |
| Shawn A. Scranton | M | 60 |
Salmedix, Inc.
Salmedix, Inc. Pharmaceuticals: MajorHealth Technology Salmedix, Inc. develops oncology and small molecule drugs to treat hematological malignancies. The company's product, Treanda, is currently in Phase II clinical trials in the United States and Canada for the treatment of indolent (slowly progressing) non-Hodgkin's lymphoma. It was founded in 2000 and is located in San Diego, CA. | 4 years |
| Ronald C. Griffith | M | 76 | - | |
| Richard K. Brown | M | 71 | - | |
| Richard DiMarchi | M | 71 | 7 years | |
| Mark K. Wedel | M | 77 | 7 years | |
| Patrick Keran | M | 52 | 2 years | |
| Karin Eastham | F | 74 |
Salmedix, Inc.
Salmedix, Inc. Pharmaceuticals: MajorHealth Technology Salmedix, Inc. develops oncology and small molecule drugs to treat hematological malignancies. The company's product, Treanda, is currently in Phase II clinical trials in the United States and Canada for the treatment of indolent (slowly progressing) non-Hodgkin's lymphoma. It was founded in 2000 and is located in San Diego, CA. | - |
| William R. Shanahan | M | 74 | 6 years | |
| Sam Wertheimer | M | 63 |
Salmedix, Inc.
Salmedix, Inc. Pharmaceuticals: MajorHealth Technology Salmedix, Inc. develops oncology and small molecule drugs to treat hematological malignancies. The company's product, Treanda, is currently in Phase II clinical trials in the United States and Canada for the treatment of indolent (slowly progressing) non-Hodgkin's lymphoma. It was founded in 2000 and is located in San Diego, CA. | 1 years |
| Lisa R. Grillone | M | 74 | 10 years | |
| Gary Patou | M | 65 | 6 years | |
| Gary T. Elliott | M | - |
Salmedix, Inc.
Salmedix, Inc. Pharmaceuticals: MajorHealth Technology Salmedix, Inc. develops oncology and small molecule drugs to treat hematological malignancies. The company's product, Treanda, is currently in Phase II clinical trials in the United States and Canada for the treatment of indolent (slowly progressing) non-Hodgkin's lymphoma. It was founded in 2000 and is located in San Diego, CA. | 3 years |
| Wendy Johnson | F | 72 |
Salmedix, Inc.
Salmedix, Inc. Pharmaceuticals: MajorHealth Technology Salmedix, Inc. develops oncology and small molecule drugs to treat hematological malignancies. The company's product, Treanda, is currently in Phase II clinical trials in the United States and Canada for the treatment of indolent (slowly progressing) non-Hodgkin's lymphoma. It was founded in 2000 and is located in San Diego, CA. | 3 years |
| Aaron Davidson | M | 55 |
Salmedix, Inc.
Salmedix, Inc. Pharmaceuticals: MajorHealth Technology Salmedix, Inc. develops oncology and small molecule drugs to treat hematological malignancies. The company's product, Treanda, is currently in Phase II clinical trials in the United States and Canada for the treatment of indolent (slowly progressing) non-Hodgkin's lymphoma. It was founded in 2000 and is located in San Diego, CA. | 2 years |
| Susan Knudson | F | 60 | - | |
| Jennifer Giottonini Cayer | F | - | 1 years | |
| Jeffrey Black | M | 55 | 2 years | |
| Douglas L. Cole | M | 77 | 13 years | |
| Muthiah Manoharan | M | - | 13 years | |
| Jon T. Holmlund | M | 67 | 7 years | |
| David Slack | M | 61 | 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 62 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Ethel M. Koczon
- Personal Network